Route of Administration Segment Analysis: Topical (Largest Segment) vs Oral (Fastest-Growing Segment)

The topical segment dominated the fungal keratitis treatment market in 2026, supported by its direct delivery of antifungal therapy to the affected ocular surface and its established role in managing localized fungal infections. Topical administration can achieve targeted exposure at the site of infection while avoiding the broader systemic exposure associated with oral therapy. Its practical use in ophthalmic treatment and compatibility with routine clinical management continue to reinforce its position, particularly where localized therapy is appropriate.

Oral treatment is emerging as the fastest-growing route as clinicians increasingly use systemic therapy when infection is severe, persistent, or inadequately controlled through local treatment alone. Oral antifungal agents can provide broader drug exposure and may complement topical therapy in more complicated cases. Greater clinical awareness of aggressive fungal infections and the need for comprehensive treatment strategies are supporting increased consideration of oral administration.

Distribution Channel Segment Analysis: Hospitals (Largest Segment) vs Drug Stores (Fastest-Growing Segment)

Hospitals represented the largest distribution channel in the fungal keratitis treatment market in 2026, reflecting the need for specialist evaluation and medically supervised treatment of potentially serious corneal infections. Diagnosis and treatment often require ophthalmic expertise, diagnostic assessment, and close monitoring, making hospital-based care an important point of access for antifungal therapies. The concentration of specialized services and treatment infrastructure within hospitals continues to support their leading role in distribution.

Drug stores are experiencing the fastest growth as greater awareness of eye health and improving access to prescription and supportive therapies expand treatment availability outside hospital settings. Drug stores can provide greater convenience for patients requiring medication refills or ongoing treatment after clinical evaluation. Expanding outpatient care and increasing preference for accessible community-based healthcare services are contributing to the rising importance of this channel.